deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT00337272

Treating Chronic Insomnia in Breast Cancer Patients

Phase IV: Treatment of Chronic Insomnia in Patients With Breast Cancer Following Completion of Chemotherapy

Sponsor: Accelerated Community Oncology Research Network

Conditions Chronic Insomnia
Interventions Placebo Ramelteon
Updated 7 times since 2017 Last updated: Aug 18, 2011 Started: Aug 31, 2006 Primary completion: Aug 31, 2008 Completion: Jan 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of enrollment.

Other terminated trials from Accelerated Community Oncology Research Network

See all terminations from Accelerated Community Oncology Research Network

This PHASE4 trial investigates Chronic Insomnia and is currently terminated or withdrawn. Accelerated Community Oncology Research Network leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Accelerated Community Oncology Research Network
  • Takeda Pharmaceuticals North America, Inc.
Data source: Accelerated Community Oncology Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations